Malignant fi brous histiocytoma (MFH) of the mandible is rare. We describe a case of MFH of the mandible with metastatic disease to the lungs. To our knowledge only 30 cases have been reported prior to the present case. In previously reported cases, there was a strong tendency for the posterior portion of the mandible to be affected by MFH; ours is only the second reported case involving the anterior portion of the mandible. We review the diagnosis, pathology, and treatment of this rare malignancy.
Introduction
Malignant fi brous histiocytoma (MFH), also known as malignant fi brous xanthoma, pleomorphic fi brous histiocytoma, pleomorphic fi brous xanthoma, and undifferentiated pleomorphic sarcoma, is the most common soft-tissue sarcoma of adulthood. [1] [2] [3] Described by O'Brien and Stout in 1964 1 as a soft-tissue sarcoma, this entity was fi rst described by Feldman and Norman 2 in 1972 as a primary malignant tumor of bone meeting histologic criteria of MFH.
MFH typically occurs in the metaphysis of long bones of the extremities; its primary occurrence in membranous bones is quite rare. 3 In the head and neck region, the most commonly affected sites include the nasal cavity and paranasal sinuses (54%), often leading to subsequent involvement of the maxillary alveolar bone. [4] [5] [6] Involvement of the larynx, maxillary sinus, and mandible have the worst prognosis in the head and neck, with mandibular involvement accounting for only 3% of all MFH bone lesions. 7, 8 Case report A 37-year-old woman presented to our clinic with a 1-year history of increasing jaw swelling and skin breakdown. The patient denied any history of previous trauma, dental treatment, or radiation exposure. Her medical history was signifi cant for non-insulin-dependent diabetes mellitus. Physical examination revealed a fi rm, tender mass measuring approximately 7 × 9 cm and fi xed to the anterior mandible. It extended beyond the midline bilaterally, with superfi cial excoriation and ulceration of the overlying skin. Breakdown of the mucous membranes along the alveolar ridges was also noted, while the rest of the oral cavity and oropharynx were unremarkable.
On palpation of the neck, no defi nitive adenopathy was detected in the submandibular region; however, in the jugulodigastric region, the patient had palpable bilateral nodes measuring 1 to 1.5 cm. Computed tomography (CT) of the neck revealed destruction of the inner and outer cortex of the mandible, with extension of tumor into the fl oor of mouth. Both a CT scan of the chest and positron-emission tomography were performed, which demonstrated metastatic disease in the form of multiple nodes in bilateral lung fi elds.
The fi ndings of an initial fi ne-needle open biopsy suggested a sarcoma. At that time, multiple immunohistochemical stains failed to identify the subtype of the sarcoma. The patient then underwent panendoscopy, open tracheotomy, and bilateral supraomohyoid neck dissection. Composite resection of the mandible, lower lip, fl oor of the mouth, ventral tongue, and skin overlying the mandible was performed, up to 1.5 cm away from the angle of the mandible bilaterally. The lower lip and overlying skin of the mandible were fi rm, with erosions and ulcerations (fi gure 1, A and B). The overall size of the mass was 7.5 × 9.5 cm (fi gure 1, C).
Initial reconstruction was attempted with a fi bula free fl ap. However, extensive thrombosis of each anastomotic site, with subsequent lack of perfusion to the fl ap, was discovered intraoperatively. The decision was then made to conservatively close the defect with a pectoralis major myocutaneous fl ap.
Within 48 hours postoperatively, the skin paddle of the pectoralis fl ap demonstrated progressively decreasing venous outfl ow, and the patient was again taken to surgery for removal of the fl ap and primary closure of the mandibular/oral cavity defect. The patient required hospitalization and rehabilitation for many weeks. She did not undergo chemotherapy or radiation therapy and died approximately 1 year after surgery.
Initial pathology of the excised specimen revealed a widely invasive, high-grade sarcoma invading the mandible. Immunohistochemical stains were performed for further characterization of the tumor. The tumor cells were strongly positive for vimentin, S-100 protein, alpha-1 antitrypsin, and WT1 antibodies (6F-H2 type) (fi gure 2), with focal areas of positive staining for Bcl-2. These fi ndings, in conjunction with the histologic appearance of the tumor, were most consistent with MFH. No areas of osteoid or chondroid differentiation were recognized within the tumor. From the bilateral neck specimens, 1 of 59 lymph nodes was positive for metastatic high-grade sarcoma.
Discussion
MFH of the bone may occur at any age, although most cases occur in patients between the fi fth and seventh decades of life. 2, 9 The tumor appears to show a predilection for whites 9 and a male predominance (56 to 64% of cases). 10 While no etiologic factors for MFH have been identifi ed, radiation exposure has been suspected to play a causal role. 10 MFH shows a high incidence of local recurrence and metastasis, with the lungs being the most common site of spread from tumors arising in the head and neck. [9] [10] [11] [12] MFH primary in bone results in metastasis via hematogenous dissemination to the lungs rather than to regional lymph nodes.
MFH of the mandible is rare; to our knowledge only 30 cases have been reported prior to the present case. [13] [14] [15] [16] [17] [18] [19] [20] [21] In previously reported cases, there was a strong tendency for the posterior portion of the mandible to be affected by MFH, 10, 13 with only one reported case occurring in the anterior portion of the mandible. 13 Ours is the second such case. Abdul-Karim et al described the largest series of MFH cases, concluding that MFH of the jaw has a distinct clinical behavior exclusive to this anatomic site-highly aggressive with a high rate of local recurrence and frequent metastasis. 22 The varied histologic appearance of MFH can make its pathologic identifi cation challenging. It can be subdivided into 5 categories based on the tumor's predominant histologic characteristics: (1) storiform-pleomorphic, (2) myxoid, (3) giant-cell, (4) infl ammatory, and (5) angiomatoid. 10 The storiform-pleomorphic subtype is most common, while the myxoid type accounts for 25% of cases. 22, 23 The remaining three types are sparsely described in the literature.
In the head and neck region, the majority of cases of MFH are of the storiform-pleomorphic and myxoid subtypes. 10 These tumors typically occur in the sinonasal tract (30%), soft tissue of the neck (10 to 15%), major salivary glands (5 to 15%), oral cavity (5 to 15%), and mandible (3%). 24, 25 Although our patient was given the diagnosis of MFH, the neoplasm was very poorly differentiated and could not be subtyped.
Because of its aggressive nature, MFH has a reported survival rate of 60% at 2 years, with a high incidence of recurrence (44%) and metastasis (44%). 26 This tumor demonstrates microscopic spread along the fascial planes and muscle fascicles beyond the confi nes of the tumor capsule. 10 Enucleation typically results in recurrence in the majority of patients (44 to 73%), making wide excision of these tumors mandatory to remove diffuse microscopic disease. 10, 27 Radical surgery, including removal of adjacent normal tissues with a minimum of 3-cm tumor-free margins, is ideal to decrease recurrence. 9 The use of radiation and chemotherapy in the treatment of MFH of the mandible has yet to be well established. 3, 22 Surgical intervention with administration of various chemotherapeutic agents-such as methotrexate, cisplatin, doxorubicin, cyclophosphamide, actinomycin-D, vincristine, dacarbazine, and ifosfamide, with or without radiation, have been used in patients with soft-tissue sarcomas. However the effi cacy of these combined-modality treatments for MFH of bone has not been determined. 9, 22, 28, 29 Therefore, these modalities are best reserved for patients who are poor surgical candidates or for inoperable cases.
In conclusion, aggressive surgical intervention with wide resection and tumor-free margins is necessary to decrease the rate of MFH recurrence. This tumor has a high incidence of metastasis, namely to the lungs, and any patient suspected to have this disease must undergo a thorough metastatic workup. The role of radiation and chemotherapy remains undefi ned and should be reserved for select cases in which surgical intervention is not possible. 
